The invention relates to three-element co-ligand iridium complexes with novel ligands. The ligands in molecules of the iridium complexes in the series are 2-(4,6-bis(trifluoromethyl)pyridine-3-)quinoline, 2-(4,6-bis(trifluoromethyl)pyridine-4-)quinoline, 2-(4,6-bis(trifluoromethyl)pyridine-3-)isoquinoline, 2-(4,6-bis(trifluoromethyl)pyridine-4-)isoquinoline, 2-(4,6-bis(trifluoromethyl)pyridine-3-)quinazoline, 2-(4,6-bis(trifluoromethyl)pyridine-4-)quinazoline, 2-(4,6-bis(trifluoromethyl)pyridine-3-)phthalazine and 2-(4,6-bis(trifluoromethyl)pyridine-4-)phthalazine derivatives. The novel iridium complexes have the advantages that the luminous efficiency is high, the chemical property is stable, sublimation purification is easy and the like, and besides, the performance of a device is good. The luminous intensity and efficiency of the ligands can be adjusted in the wavelength coverage of red light through a molecular structure modifying the ligands, which brings convenience to design and production of organic electroluminescent displays and lighting sources.